<b>Format of the Annual Disclosure to be made by an entity identified as a Large Corporate.</b><br/><br/> <table border=''1px''> <tr> <td><b>Sr. No.</b></td> <td><b>Particulars</b></td> ....
PFIZER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Pfizer Ltd has informed the stock exchanges that it does not qualify as a 'Large Corporate' under SEBI's October 2023 circular, and therefore the annual disclosure requirement does not apply to it. The company confirmed three things: it has not issued any debt securities or non-convertible redeemable preference shares, it has no outstanding long-term borrowings exceeding Rs. 1,000 Crores, and it has not obtained any credit ratings on borrowings. This was filed by Prajeet Nair, Director – Corporate Services & Company Secretary, on April 29, 2025.
This is a routine compliance filing with no material impact on shareholders or the stock price. It simply confirms Pfizer's debt and borrowings profile remains modest enough to stay below the SEBI Large Corporate threshold.